K230927 is an FDA 510(k) clearance for the OptiMesh Multiplanar Expandable Interbody Fusion System. Classified as Intervertebral Body Graft Containment Device (product code OQB), Class II - Special Controls.
Submitted by Spineology, Inc. (Saint Paul, US). The FDA issued a Cleared decision on November 1, 2023 after a review of 212 days - an extended review cycle.
This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3085 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.
View all Spineology, Inc. devices